Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Audinot, V; Newman-Tancredi, A; Cussac, D; Millan, MJ
   Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT1D receptors
   NEUROPSYCHOPHARMACOLOGY
   
   V. Audinot et al., "Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT1D receptors", NEUROPSYCH, 25(3), 2001, pp. 410-422
2. Audinot, V; Newman-Tancredi, A; Millan, MJ
   Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms
   NEUROPHARMACOLOGY
   
   V. Audinot et al., "Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms", NEUROPHARM, 40(1), 2001, pp. 57-64
3. Newman-Tancredi, A; Chaput, C; Touzard, M; Millan, MJ
   Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a [S-35]GTP gamma S autoradiography study
   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
   
   A. Newman-Tancredi et al., "Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a [S-35]GTP gamma S autoradiography study", N-S ARCH PH, 363(4), 2001, pp. 391-398
4. Millan, MJ; Gobert, A; Lejeune, F; Newman-Tancredi, A; Rivet, JM; Auclair, A; Peglion, JL
   S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine
   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
   
   M.J. Millan et al., "S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine", J PHARM EXP, 298(2), 2001, pp. 565-580
5. Millan, MJ; Cussac, D; Milligan, G; Carr, C; Audinot, V; Gobert, A; Lejeune, F; Rivet, JM; Brocco, M; Duqueyroix, D; Nicolas, JP; Boutin, JA; Newman-Tancredi, A
   Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization
   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
   
   M.J. Millan et al., "Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization", J PHARM EXP, 297(3), 2001, pp. 876-887
6. Cordi, AA; Berque-Bestel, I; Persigand, T; Lacoste, JM; Newman-Tancredi, A; Audinot, V; Millan, MJ
   Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties
   JOURNAL OF MEDICINAL CHEMISTRY
   
   A.A. Cordi et al., "Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties", J MED CHEM, 44(5), 2001, pp. 787-805
7. Newman-Tancredi, A; Verriele, L; Touzard, M; Millan, MJ
   Efficacy of antipsychotic agents at human 5-HT1A receptors determined by [H-3]WAY100,635 binding affinity ratios: Relationship to efficacy for G-protein activation
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   A. Newman-Tancredi et al., "Efficacy of antipsychotic agents at human 5-HT1A receptors determined by [H-3]WAY100,635 binding affinity ratios: Relationship to efficacy for G-protein activation", EUR J PHARM, 428(2), 2001, pp. 177-184
8. Millan, MJ; Newman-Tancredi, A; Duqueyroix, D; Cussac, D
   Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   M.J. Millan et al., "Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase", EUR J PHARM, 424(1), 2001, pp. 13-17
9. Newman-Tancredi, A; Verriele, L; Millan, MJ
   Differential modulation by GTP gamma S of agonist and inverse agonist binding to h5-HT1A receptors revealed by [H-3]-WAY100,635
   BRITISH JOURNAL OF PHARMACOLOGY
   
   A. Newman-Tancredi et al., "Differential modulation by GTP gamma S of agonist and inverse agonist binding to h5-HT1A receptors revealed by [H-3]-WAY100,635", BR J PHARM, 132(2), 2001, pp. 518-524
10. Millan, MJ; Newman-Tancredi, A; Quentric, Y; Cussac, D
    The '' selective '' dopamine D-1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin(2C) receptors
    PSYCHOPHARMACOLOGY
    
    M.J. Millan et al., "The '' selective '' dopamine D-1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin(2C) receptors", PSYCHOPHAR, 156(1), 2001, pp. 58-62
11. Millan, MJ; Gobert, A; Rivet, JM; Adhumeau-Auclair, A; Cussac, D; Newman-Tancredi, A; Dekeyne, A; Nicolas, JP; Lejeune, F
    Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    M.J. Millan et al., "Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram", EUR J NEURO, 12(3), 2000, pp. 1079-1095
12. Gobert, A; Rivet, JM; Lejeune, F; Newman-Tancredi, A; Adhumeau-Auclair, A; Nicolas, JP; Cistarelli, L; Melon, C; Millan, MJ
    Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat
    SYNAPSE
    
    A. Gobert et al., "Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat", SYNAPSE, 36(3), 2000, pp. 205-221
13. Millan, MJ; Newman-Tancredi, A; Audinot, V; Cussac, D; Lejeune, F; Nicolas, JP; Coge, F; Galizzi, JP; Boutin, JA; Rivet, JM; Dekeyne, A; Gobert, A
    Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states
    SYNAPSE
    
    M.J. Millan et al., "Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states", SYNAPSE, 35(2), 2000, pp. 79-95
14. Morris, BJ; Newman-Tancredi, A; Audinot, V; Simpson, CS; Millan, MJ
    Activation of dopamine D-3 receptors induces c-fos expression in primary cultures of rat striatal neurons
    JOURNAL OF NEUROSCIENCE RESEARCH
    
    B.J. Morris et al., "Activation of dopamine D-3 receptors induces c-fos expression in primary cultures of rat striatal neurons", J NEUROSC R, 59(6), 2000, pp. 740-749
15. Newman-Tancredi, A; Chaput, C; Touzard, M; Millan, MJ
    [S-35]-GTP gamma S autoradiography reveals alpha(2) adenoceptor-mediated G-protein activation in amygdala and lateral septum
    NEUROPHARMACOLOGY
    
    A. Newman-Tancredi et al., "[S-35]-GTP gamma S autoradiography reveals alpha(2) adenoceptor-mediated G-protein activation in amygdala and lateral septum", NEUROPHARM, 39(6), 2000, pp. 1111-1113
16. Cussac, D; Newman-Tancredi, A; Nicolas, JP; Boutin, JA; Millan, MJ
    Antagonist properties of the novel antipsychotic, S16924, at cloned, humanserotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    D. Cussac et al., "Antagonist properties of the novel antipsychotic, S16924, at cloned, humanserotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol", N-S ARCH PH, 361(5), 2000, pp. 549-554
17. Cussac, D; Newman-Tancredi, A; Sezgin, L; Millan, MJ
    [H-3]S33084: a novel, selective and potent radioligand at cloned, human dopamine D-3 receptors
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    D. Cussac et al., "[H-3]S33084: a novel, selective and potent radioligand at cloned, human dopamine D-3 receptors", N-S ARCH PH, 361(5), 2000, pp. 569-572
18. Cussac, D; Newman-Tancredi, A; Quentric, Y; Millan, MJ
    An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [H-3]phosphatidylinositol depletion
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    D. Cussac et al., "An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [H-3]phosphatidylinositol depletion", N-S ARCH PH, 361(2), 2000, pp. 221-223
19. Newman-Tancredi, A; Audinot, V; Moreira, C; Verriele, L; Millan, MJ
    Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT1B receptor/G-protein stoichiometry
    MOLECULAR PHARMACOLOGY
    
    A. Newman-Tancredi et al., "Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT1B receptor/G-protein stoichiometry", MOLEC PHARM, 58(5), 2000, pp. 1042-1049
20. Millan, MJ; Dekeyne, A; Newman-Tancredi, A; Cussac, D; Audinot, V; Milligan, G; Duqueyroix, D; Girardon, S; Mullot, J; Boutin, JA; Nicolas, JP; Renouard-Try, A; Lacoste, JM; Cordi, A
    S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M.J. Millan et al., "S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine", J PHARM EXP, 295(3), 2000, pp. 1192-1205
21. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Dubuffet, T; Lavielle, G
    S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M.J. Millan et al., "S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626", J PHARM EXP, 293(3), 2000, pp. 1048-1062
22. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Adhumeau, A; Brocco, M; Nicolas, JP; Boutin, JA; Despaux, N; Peglion, JL
    S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M.J. Millan et al., "S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile", J PHARM EXP, 292(1), 2000, pp. 38-53
23. Millan, MJ; Brocco, M; Rivet, JM; Audinot, V; Newman-Tancredi, A; Maiofiss, L; Queriaux, S; Despaux, N; Peglion, JL; Dekeyne, A
    S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine,and 11 other antipsychotic agents
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M.J. Millan et al., "S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine,and 11 other antipsychotic agents", J PHARM EXP, 292(1), 2000, pp. 54-66
24. Cussac, D; Newman-Tancredi, A; Sezgin, L; Millan, MJ
    The novel antagonist, S33084, and CR218,231 interact selectively with cloned and native, rat dopamine D-3 receptors as compared with native, rat dopamine D-2 receptors
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    D. Cussac et al., "The novel antagonist, S33084, and CR218,231 interact selectively with cloned and native, rat dopamine D-3 receptors as compared with native, rat dopamine D-2 receptors", EUR J PHARM, 394(1), 2000, pp. 47-50
25. Dubuffet, T; Newman-Tancredi, A; Cussac, D; Audinot, V; Loutz, A; Millan, MJ; Lavielle, G
    Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D-3 receptor antagonists
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    T. Dubuffet et al., "Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D-3 receptor antagonists", BIOORG MED, 9(14), 1999, pp. 2059-2064
26. Millan, MJ; Brocco, M; Gobert, A; Joly, F; Bervoets, K; Rivet, JM; Newman-Tancredi, A; Audinot, V; Maurel, S
    Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    M.J. Millan et al., "Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat", EUR J NEURO, 11(12), 1999, pp. 4419-4432
27. Millan, MJ; Gobert, A; Audinot, V; Dekeyne, A; Newman-Tancredi, A
    Inverse agonists and serotonergic transmission: From recombinant, human serotonin (5-HT)(1B) receptors to G-protein coupling and function in corticolimbic structures in vivo
    NEUROPSYCHOPHARMACOLOGY
    
    M.J. Millan et al., "Inverse agonists and serotonergic transmission: From recombinant, human serotonin (5-HT)(1B) receptors to G-protein coupling and function in corticolimbic structures in vivo", NEUROPSYCH, 21(2), 1999, pp. S61-S67
28. Newman-Tancredi, A; Cussac, D; Audinot, V; Millan, MJ
    Actions of roxindole at recombinant human dopamine D-2, D-3 and D-4 and serotonim 5-HT1A, 5-HT1B and 5-HT1D receptors
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    A. Newman-Tancredi et al., "Actions of roxindole at recombinant human dopamine D-2, D-3 and D-4 and serotonim 5-HT1A, 5-HT1B and 5-HT1D receptors", N-S ARCH PH, 359(6), 1999, pp. 447-453
29. Cussac, D; Newman-Tancredi, A; Pasteau, V; Millan, MJ
    Human dopamine D-3 receptors mediate mitogen- activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism
    MOLECULAR PHARMACOLOGY
    
    D. Cussac et al., "Human dopamine D-3 receptors mediate mitogen- activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism", MOLEC PHARM, 56(5), 1999, pp. 1025-1030
30. Newman-Tancredi, A; Cussac, D; Audinot, V; Pasteau, V; Gavaudan, S; Millan, MJ
    G protein activation by human dopamine D-3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5 '-O-(3-[S-35]thio)-triphosphate binding and antibody study
    MOLECULAR PHARMACOLOGY
    
    A. Newman-Tancredi et al., "G protein activation by human dopamine D-3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5 '-O-(3-[S-35]thio)-triphosphate binding and antibody study", MOLEC PHARM, 55(3), 1999, pp. 564-574
31. Newman-Tancredi, A; Rivet, JM; Chaput, C; Touzard, M; Verriele, L; Millan, MJ
    The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [S-35]GTP gamma S and [H-3]S15535 autoradiography study
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    A. Newman-Tancredi et al., "The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [S-35]GTP gamma S and [H-3]S15535 autoradiography study", EUR J PHARM, 384(2-3), 1999, pp. 111-121